Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Forodesine hydrochloride

EU orphan designation number: EU/3/06/421   
Active ingredient: Forodesine hydrochloride
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Mundipharma Research Limited
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0GW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2006 Orphan designation EMEA/OD/070/06 (2006)7016 of 18/12/2006
7/08/2007 Change of name and/or address of sponsor